COMPANY PROFILE / #2716
Brainomix
Oxford, United KingdomVenture Capital-Backed
OVERVIEW
Developer of medical imaging biomarkers and software systems designed to support clinical decision-making for neurological and cerebrovascular diseases. The company uses artificial intelligence to provide a rapid, standardized assessment of stroke patients' CT scans, supporting consistent treatment decisions by medical professionals, irrespective of their experience or expertise, enabling healthcare professionals to make informed treatment decisions as early as possible and optimizing patient outcomes.
已融资63.79
最新估值76.11
员工数86
成立年份2010
公司概况
- Companies
- Brainomix
- Description
- Developer of medical imaging biomarkers and software systems designed to support clinical decision-making for neurological and cerebrovascular diseases. The company uses artificial intelligence to provide a rapid, standardized assessment of stroke patients' CT scans, supporting consistent treatment decisions by medical professionals, irrespective of their experience or expertise, enabling healthcare professionals to make informed treatment decisions as early as possible and optimizing patient outcomes.
- Website
- www.brainomix.com
- HQ Location
- Oxford, United Kingdom
- Year Founded
- 2010
- Keywords
- ai medical imaging, biomarkers detection, clinical decision making, imaging platform, imaging software, medical imaging software, stroke diagnostics
- Competitors
- CureMetrix, Zebra Medical Vision, Aidoc, VoxelCloud, Advantis Medical Imaging, SigTuple, Cercare Medical, Olea Medical, Vista.ai, MIM Software, Mirada Medical, Velocity Medical Solutions, Circle Cardiovascular Imaging, Pieces, ClinicalPath, AccuVein, icometrix, Viz.ai, EOS Imaging, Pie Medical Imaging, Lifetrack Medical Systems, VisualDx, Quantib, Mevion Medical Systems, P-Cure, RapidAI, Arterys, Medis Medical Imaging, ImmersiveTouch, Accuray, Caption Care, Oncora Medical, inHEART, Ablatus Therapeutics, Radialogica, TomTec Imaging Systems, NorthStar (Pharmaceuticals), Intrasense
- Ownership Status
- Privately Held (backing)
- Company Financing Status
- Venture Capital-Backed
融资与估值
- Total Raised
- 63.79
- First Financing Date
- 02-Nov-2010
- First Financing Size
- —
- First Financing Valuation
- —
- Last Financing Date
- 05-May-2026
- Last Financing Deal Type
- Later Stage VC
- Last Financing Size
- 25.14
- Last Financing Valuation
- 76.11
- Last Financing Status
- Completed
- Last Known Valuation
- 76.11
- Last Known Valuation Date
- 05-May-2026
- Last Known Valuation Deal Type
- Later Stage VC
- Valuation Estimate
- 82.42
- Valuation Estimate Growth Rate
- 8.30%
- Active Investors
- Andrew Barker, Boehringer Ingelheim Venture Fund, Endeavor Greece, Epiphany Capital, Horizon 2020, Hostplus Superannuation Fund, Innovate UK, IP Group Australia, LifeSci Venture Partners, Modi Ventures, Oxford University Innovation, Parkwalk Advisors, Tencent Holdings, University of Oxford
- # Active Investors
- 14
- Acquirers
- —
团队与联系人
- Employees
- 86
- Employee Growth %
- 19.44%
- Employee History
- 2026: 86, 2025: 72, 2024: 73, 2023: 70, 2022: 45, 2021: 39, 2020: 33
- Primary Contact
- Michalis Papadakis
- Primary Contact Title
- Co-Founder, Chief Executive Officer and Board Member
- Primary Contact Email
- mpapadakis@brainomix.com
- Primary Contact Phone
- +44 (0)18 6558 2730
增长与经营
- Revenue
- 7.99
- Revenue Growth %
- 32.66%
- Growth Rate
- 0.30%
- Growth Rate % Change
- —
- Growth Rate Percentile
- 92
- Size Multiple
- 10.75x
- Size Multiple % Change
- -42.75%
- Size Multiple Change
- -8.03x
- Size Multiple Percentile
- 93
- Majestic Referring Domains
- 697
- SimilarWeb Unique Visitors
- —
- SimilarWeb Unique Visitors Change
- —
- SimilarWeb Growth Rate
- —
- SimilarWeb Growth Rate Percentile
- —
- Success Probability Over Time – 1 Year
- 11%
- Success Probability Over Time – 3 Year
- 33%
- Success Probability Over Time – 5 Year
- 47%
记录来源：public.companies · 原始序号 #2716 · 所有字段均按数据库原值展示。